In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.

MLA

Hirschfield, Hadassa, et al. “In Vitro Modeling of Hepatocellular Carcinoma Molecular Subtypes for Anti-Cancer Drug Assessment.” Experimental & Molecular Medicine, vol. 50, no. 1, Jan. 2018, p. e419. EBSCOhost, https://doi.org/10.1038/emm.2017.164.

APA

Hirschfield, H., Bian, C. B., Higashi, T., Nakagawa, S., Zeleke, T. Z., Nair, V. D., Fuchs, B. C., & Hoshida, Y. (2018). In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment. Experimental & Molecular Medicine, 50(1), e419. https://doi.org/10.1038/emm.2017.164

Chicago

Hirschfield, Hadassa, C Billie Bian, Takaaki Higashi, Shigeki Nakagawa, Tizita Z Zeleke, Venugopalan D Nair, Bryan C Fuchs, and Yujin Hoshida. 2018. “In Vitro Modeling of Hepatocellular Carcinoma Molecular Subtypes for Anti-Cancer Drug Assessment.” Experimental & Molecular Medicine 50 (1): e419. doi:10.1038/emm.2017.164.